Kaley Blankenship

712 total citations
6 papers, 61 citations indexed

About

Kaley Blankenship is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Kaley Blankenship has authored 6 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Biotechnology. Recurrent topics in Kaley Blankenship's work include Cancer Research and Treatments (2 papers), Cancer therapeutics and mechanisms (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Kaley Blankenship is often cited by papers focused on Cancer Research and Treatments (2 papers), Cancer therapeutics and mechanisms (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Kaley Blankenship collaborates with scholars based in United States and Spain. Kaley Blankenship's co-authors include Nicholas B. Anthony, Walter Bottje, Elizabeth Greene, Sami Dridi, Sara Orlowski, Elizabeth Stewart, Xin Huang, Colleen Reilly, Michael A. Dyer and Brent A. Orr and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Developmental Cell.

In The Last Decade

Kaley Blankenship

5 papers receiving 61 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kaley Blankenship United States	3	26	24	16	14	11	6	61
Gengsheng Yu China	5	34 1.3×	16 0.7×	16 1.0×	10 0.7×	7 0.6×	9	66
Priya Kundra United States	4	39 1.5×	14 0.6×	28 1.8×	6 0.4×	7 0.6×	4	150
Brittney Gordon United States	3	36 1.4×	23 1.0×	16 1.0×	15 1.1×		5	59
Mark W. Betten United States	2	24 0.9×	17 0.7×	9 0.6×	13 0.9×		2	37
Foad Green United States	1	41 1.6×	6 0.3×	20 1.3×	5 0.4×		2	120
Shuqun Zhang China	6	31 1.2×	9 0.4×	26 1.6×	12 0.9×		9	70
Ruth Witt Germany	4	40 1.5×	9 0.4×	12 0.8×	12 0.9×		7	65
M. Rosario Alonso Spain	2	66 2.5×	34 1.4×	38 2.4×	20 1.4×		2	107
Ángel M. Martínez‐Montes Spain	5	42 1.6×	31 1.3×	8 0.5×	27 1.9×		5	60
Laura Fankhauser United Kingdom	2	31 1.2×	20 0.8×	18 1.1×	7 0.5×		2	51

Countries citing papers authored by Kaley Blankenship

Since Specialization

Citations

This map shows the geographic impact of Kaley Blankenship's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaley Blankenship with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaley Blankenship more than expected).

Fields of papers citing papers by Kaley Blankenship

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaley Blankenship. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaley Blankenship. The network helps show where Kaley Blankenship may publish in the future.

Co-authorship network of co-authors of Kaley Blankenship

This figure shows the co-authorship network connecting the top 25 collaborators of Kaley Blankenship. A scholar is included among the top collaborators of Kaley Blankenship based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaley Blankenship. Kaley Blankenship is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Blankenship, Kaley, Debolina Ganguly, Nathaniel Twarog, et al.. (2025). The Combination of PARP and Topoisomerase 1 Inhibitors Improves Radiation Therapy for Ewing Sarcoma. Cancer Science. 116(6). 1703–1714.

2.

McEvoy, Justina, Brittney Gordon, Kaley Blankenship, et al.. (2024). Abstract 143: Molecular profiling of tumor-initiation events in rhabdomyosarcoma uncovers mitochondrial vulnerabilities. Cancer Research. 84(6_Supplement). 143–143. 1 indexed citations

3.

Stewart, Elizabeth, Kaley Blankenship, Burgess B. Freeman, Sara M. Federico, & Michael A. Dyer. (2023). Abstract 6716: Preclinical evaluation of nano-liposomal irinotecan in pediatric solid tumor patient-derived xenografts. Cancer Research. 83(7_Supplement). 6716–6716. 2 indexed citations

4.

Patel, Anand G., Xiang Chen, Xin Huang, et al.. (2022). The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma. Developmental Cell. 57(10). 1226–1240.e8. 37 indexed citations

5.

Stewart, Elizabeth, Victoria Honnell, Kaley Blankenship, et al.. (2017). Targeting the cell cycle for cancer therapy in rhabdomyosarcoma.. Journal of Clinical Oncology. 35(15_suppl). 10535–10535. 1 indexed citations

6.

Blankenship, Kaley, Sara Orlowski, Elizabeth Greene, et al.. (2015). Differential expression of feeding-related hypothalamic neuropeptides in the first generation of quails divergently selected for low or high feed efficiency. Neuropeptides. 58. 31–40. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact